Nobilis Health Corp. (HLTH) News

Nobilis Health Corp. (HLTH): $0.15

0.01 (+6.09%)

POWR Rating

Component Grades








Add HLTH to Watchlist
Sign Up

Industry: Medical - Services




in industry

Filter HLTH News Items

HLTH News Results

Date Symbol Company Title Start End Change POWR Rating
Loading, please wait...

Latest HLTH News From Around the Web

Below are the latest news stories about CUE HEALTH INC that investors may wish to consider to help them evaluate HLTH as an investment opportunity.

Cue Health Inc. (NASDAQ:HLTH) Not Doing Enough For Some Investors As Its Shares Slump 28%

Cue Health Inc. ( NASDAQ:HLTH ) shareholders won't be pleased to see that the share price has had a very rough month...

Yahoo | November 10, 2023

Acon receives first FDA clearance for over-the-counter COVID-19 antigen test

The FDA is encouraging manufacturers to transition to traditional review pathways now that the acute phase of the COVID-19 crisis is over.

Yahoo | November 10, 2023

Cue Health Inc. (NASDAQ:HLTH) Q3 2023 Earnings Call Transcript

Cue Health Inc. (NASDAQ:HLTH) Q3 2023 Earnings Call Transcript November 8, 2023 Cue Health Inc. beats earnings expectations. Reported EPS is $-0.43, expectations were $-0.47. Operator: Good day and thank you for standing by. Welcome to the Cue Health Third Quarter 2023 Earnings Conference Call. At this time, all participants are in a listen-only mode. […]

Yahoo | November 9, 2023

Cue Health Inc (HLTH) Surpasses Revenue Expectations in Q3 2023

Revenue Climbs to $17.5 Million, Outperforming Guidance Amid FDA Reviews

Yahoo | November 8, 2023

Cue Health Reports Third Quarter 2023 Financial Results

SAN DIEGO, November 08, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, today reported financial results for the third quarter 2023.

Yahoo | November 8, 2023

Cue Health to Announce Third Quarter 2023 Financial Results

SAN DIEGO, October 25, 2023--Cue Health Inc. ("Cue") (Nasdaq: HLTH), a healthcare technology company, announced today that it will release its third quarter 2023 financial results on Wednesday, November 8, 2023. In conjunction with the release, Cue will host a conference call and webcast that day at 1:30 p.m. Pacific Time / 4:30 p.m. Eastern Time to discuss its financial results and recent highlights.

Yahoo | October 25, 2023

Augmedix, Inc. (AUGX) Soars 7.6%: Is Further Upside Left in the Stock?

Augmedix, Inc. (AUGX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revisions for the stock doesn't suggest further strength down the road.

Yahoo | October 12, 2023

Concerned Stockholders of Cue Health Send Letter to Board

LOS ANGELES, October 06, 2023--Kelly Day and other concerned stockholders sent a letter to the board of directors of Cue Health outlining their urgent concerns for the Company

Yahoo | October 6, 2023

Peer-Reviewed Independent Study Published in Microbiology Spectrum Finds Cue Health’s Molecular COVID-19 Test is as Accurate as a Lab-Based PCR Test

SAN DIEGO, October 04, 2023--Cue Health (Nasdaq: HLTH), a healthcare technology company, announced today the peer-reviewed publication of an independent clinical study - the largest of its kind on asymptomatic people - finding that Cue’s molecular COVID-19 test provides comparable accuracy to centralized lab-based RT-PCR with the advantages of convenient use at the point-of-care or home settings and fast results in 20 minutes.

Yahoo | October 4, 2023

Cue Health Adopts Limited-Duration Shareholder Rights Plan

SAN DIEGO, September 21, 2023--Cue Health (Nasdaq: HLTH), a healthcare technology company, today announced that its Board of Directors has unanimously approved the adoption of a limited-duration shareholder rights plan (the "Rights Plan") to protect the long-term interests of all shareholders. The Board adopted the Rights Plan in response to a rapid accumulation of shares by a third party. The Rights Plan is effective immediately and has a one-year term, expiring on September 20, 2024.

Yahoo | September 21, 2023

Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from!